Back to top

Novonesis upgraded to Neutral from Underperform at BNP Paribas

BNP Paribas upgraded Novonesis (NVZMY) to Neutral from Underperform with a price target of DKK 415, up from DKK 362. The firm cites valuation follo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)